Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Has results × MK-4166 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

pembrolizumab 105 Paclitaxel 65 Cyclophosphamide 65 Cisplatin 60 Carboplatin 56 Gemcitabine 48 Radiotherapy 43 Nivolumab 43 Docetaxel 38 fludarabine 37 Pemetrexed 33 Dexamethasone 32 Capecitabine 32 Lenalidomide 26 fludarabine phosphate 25 Rituximab 25 Ipilimumab 25 Doxorubicin 25 Radiation 24 Bevacizumab 24 Azacitidine 24 Vorinostat 23 Irinotecan 23 Vincristine 22 Cytarabine 21 Etoposide 20 Temozolomide 19 Oxaliplatin 19 Fluorouracil 19 atezolizumab 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02132754 2021-01-28

MK-4166-001

Merck Sharp & Dohme LLC

Phase 1 Completed

116 enrolled 61 charts

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡